Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr 28:9:638871.
doi: 10.3389/fped.2021.638871. eCollection 2021.

The Protective Role of Maternal Immunization in Early Life

Affiliations
Review

The Protective Role of Maternal Immunization in Early Life

Bianca Cinicola et al. Front Pediatr. .

Abstract

With birth, the newborn is transferred from a quasi-sterile environment to the outside world. At this time, the neonatal immune system is inexperienced and continuously subject to a process of development as it encounters different antigenic stimuli after birth. It is initially characterized by a bias toward T helper 2 phenotype, reduced T helper 1, and cytotoxic responses to microbial stimuli, low levels of memory, and effector T and B cells and a high production of suppressive T regulatory cells. The aim of this setting, during fetal life, is to maintain an anti-inflammatory state and immune-tolerance. Maternal antibodies are transferred during pregnancy through the placenta and, in the first weeks of life of the newborn, they represent a powerful tool for protection. Thus, optimization of vaccination in pregnancy represents an important strategy to reduce the burden of neonatal infections and sepsis. Beneficial effects of maternal immunization are universally recognized, although the optimal timing of vaccination in pregnancy remains to be defined. Interestingly, the dynamic exchange that takes place at the fetal-maternal interface allows the transfer not only of antibodies, but also of maternal antigen presenting cells, probably in order to stimulate the developing fetal immune system in a harmless way. There are still controversial effects related to maternal immunization including the so called "immunology blunting," i.e., a dampened antibody production following infant's vaccination in those infants who received placentally transferred maternal immunity. However, clinical relevance of this phenomenon is still not clear. This review will provide an overview of the evolution of the immune system in early life and discuss the benefits of maternal vaccination. Current maternal vaccination policies and their rationale will be summarized on the road to promising approaches to enhance immunity in the neonate.

Keywords: immune system; maternal immunization; neonate; pregnancy; vaccination.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
(A) Progressive increase of vaccine-specific antibody production and transplacental transfer after maternal immunization during pregnancy. Maternal vaccination may also impact the transfer of maternal immune cells to the offspring, priming the developing fetal immune system. (B) Breastfeeding enables the transfer of vaccine-specific maternal antibodies, mainly sIgA, and immune cells secreted through colostrum and breast milk to the infant. Created with BioRender.com.

Similar articles

Cited by

References

    1. Popescu CR, Cavanagh MMM, Tembo B, Chiume M, Lufesi N, Goldfarb DM, et al. . Neonatal sepsis in low-income countries: epidemiology, diagnosis and prevention. Exp Rev Anti Infect Ther. (2020) 18:443–52. 10.1080/14787210.2020.1732818 - DOI - PubMed
    1. Dowling DJ, Levy O. Ontogeny of early life immunity. Trends Immunol. (2014) 35:299–310. 10.1016/j.it.2014.04.007 - DOI - PMC - PubMed
    1. Aaby P, Martins CL, Garly M-L, Andersen A, Fisker AB, Claesson MH, et al. . Measles vaccination in the presence or absence of maternal measles antibody: impact on child survival. Clin Infect Dis. (2014) 59:484–92. 10.1093/cid/ciu354 - DOI - PMC - PubMed
    1. Gans H, Yasukawa L, Rinki M, DeHovitz R, Forghani B, Beeler J, Audet S, et al. . Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months. J Infect Dis. (2001) 184:817–26. 10.1086/323346 - DOI - PubMed
    1. Whittaker E, Goldblatt D, McIntyre P, Levy O. Neonatal immunization: rationale, current state, and future prospects. Front Immunol. (2018) 9:532. 10.3389/fimmu.2018.00532 - DOI - PMC - PubMed

LinkOut - more resources